To view this email as a web page, click here.

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

FDA ACTIONS

TODAY'S HEADLINES

New device could be breakthrough for diabetics

FDA recently expanded approval of the G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose testing for diabetics. Read more

Why 2016 drug approvals fell

While FDA approved far fewer new drugs in 2016 than 2015, the agency quickly approved novel and breakthrough therapies. Read more

CONTINUING PHARMACY EDUCATION

Key cogs in the management of Parkinson's disease

This month's CE activity, "Key cogs in the management of Parkinson's disease," is open for pharmacists and pharmacy technicians.
The goal of this activity is to assist pharmacists and pharmacy technicians in managing difficult-to-treat symptoms of Parkinson's disease.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

New diabetes combo drug available soon

A new combination drug for type 2 diabetes will available in the United States in the coming months. Read more

January 4, 2017

Related Articles

FDA approves 2 injectable diabetes drugs

US drug spending predicted to drop

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us